US Stock MarketDetailed Quotes

SEEL Seelos Therapeutics

Watchlist
  • 1.7500
  • -0.1501-7.90%
Trading May 20 12:15 ET
3.80MMarket Cap-50P/E (TTM)

Seelos Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
55.14%-4.64M
61.18%-23.91M
85.40%-1.91M
48.09%-5.75M
71.05%-5.9M
39.29%-10.35M
-25.74%-61.6M
28.62%-13.09M
-5.37%-11.07M
-129.31%-20.4M
Net income from continuing operations
80.17%-2.66M
48.48%-37.88M
70.77%-5.45M
153.55%10.5M
-38.66%-29.5M
4.07%-13.43M
-11.33%-73.53M
31.56%-18.66M
-81.27%-19.6M
-140.14%-21.27M
Operating gains losses
-177.99%-3.61M
-2,928.77%-8.84M
-3,165.00%-3.27M
-26,370.33%-23.91M
28,063.27%13.7M
2,076.50%4.63M
-109.35%-292K
-174.63%-100K
219.74%91K
-103.20%-49K
Depreciation and amortization
7.14%15K
7.55%57K
-71.70%15K
--14K
--14K
--14K
--53K
--53K
--0
--0
Other non cash items
----
47.23%6.35M
-29.65%700K
-62.61%799K
----
----
-38.29%4.31M
-81.60%995K
11,772.22%2.14M
62.11%937K
Change In working capital
117.87%456K
346.25%12.42M
38.15%5.13M
10.19%5.87M
508.54%3.97M
51.72%-2.55M
297.80%2.78M
256.69%3.71M
1,178.74%5.33M
69.47%-972K
-Change in receivables
74.15%-205K
---763K
---542K
--210K
--362K
---793K
--0
--0
--0
--0
-Change in prepaid assets
70.41%-414K
353.09%5.69M
-39.11%1.74M
73.57%2.19M
243.96%3.16M
66.43%-1.4M
22.36%-2.25M
530.12%2.86M
224.02%1.26M
-402.29%-2.2M
-Change in payables and accrued expense
414.12%1.09M
20.75%7.55M
335.17%3.95M
-14.23%3.49M
-62.14%463K
-719.64%-347K
320.65%6.26M
153.20%907K
679.50%4.07M
144.52%1.22M
-Change in other current liabilities
-15.38%-15K
95.27%-58K
68.63%-16K
---15K
---14K
98.89%-13K
---1.23M
---51K
--0
--0
Cash from discontinued investing activities
Operating cash flow
55.14%-4.64M
61.18%-23.91M
85.40%-1.91M
48.09%-5.75M
71.05%-5.9M
39.29%-10.35M
-25.74%-61.6M
28.62%-13.09M
-5.37%-11.07M
-129.31%-20.4M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-75.55%2.17M
812.27%11.38M
223.04%2.32M
645.51%2.49M
-1,734.92%-2.31M
10,591.57%8.87M
-101.43%-1.6M
-109.33%-1.89M
133.57%334K
-100.22%-126K
Net issuance payments of debt
-2.18%-1.31M
-304.71%-7.64M
-14.09%-2.15M
---1.89M
---2.31M
---1.29M
86.07%-1.89M
---1.89M
--0
--0
Net common stock issuance
-65.54%3.48M
4,039.82%18.92M
--4.48M
850.33%4.34M
--0
--10.1M
-99.61%457K
--0
--457K
--0
Proceeds from stock option exercised by employees
-93.44%4K
-9.35%97K
--0
50.00%36K
--0
-26.51%61K
-98.57%107K
--0
-67.57%24K
--0
Net other financing activities
----
----
----
----
----
----
---273K
--0
---147K
----
Cash from discontinued financing activities
Financing cash flow
-75.55%2.17M
812.27%11.38M
223.04%2.32M
645.51%2.49M
-1,734.92%-2.31M
10,591.57%8.87M
-101.43%-1.6M
-109.33%-1.89M
133.57%334K
-100.22%-126K
Net cash flow
Beginning cash position
-80.71%3M
-80.27%15.53M
-91.53%2.58M
-85.84%5.84M
-77.24%14.06M
-80.27%15.53M
402.71%78.73M
-60.29%30.51M
-52.69%41.25M
59.67%61.77M
Current changes in cash
-67.71%-2.47M
80.16%-12.54M
102.75%412K
69.66%-3.26M
59.96%-8.22M
91.31%-1.47M
-200.20%-63.2M
-887.90%-14.98M
-3.60%-10.74M
-142.30%-20.52M
End cash Position
-96.27%524K
-80.71%3M
-80.71%3M
-91.53%2.58M
-85.84%5.84M
-77.24%14.06M
-80.27%15.53M
-80.27%15.53M
-60.29%30.51M
-52.69%41.25M
Free cash flow
55.14%-4.64M
61.18%-23.91M
85.40%-1.91M
48.09%-5.75M
71.05%-5.9M
39.29%-10.35M
-25.74%-61.6M
28.62%-13.09M
-5.37%-11.07M
-129.31%-20.4M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 55.14%-4.64M61.18%-23.91M85.40%-1.91M48.09%-5.75M71.05%-5.9M39.29%-10.35M-25.74%-61.6M28.62%-13.09M-5.37%-11.07M-129.31%-20.4M
Net income from continuing operations 80.17%-2.66M48.48%-37.88M70.77%-5.45M153.55%10.5M-38.66%-29.5M4.07%-13.43M-11.33%-73.53M31.56%-18.66M-81.27%-19.6M-140.14%-21.27M
Operating gains losses -177.99%-3.61M-2,928.77%-8.84M-3,165.00%-3.27M-26,370.33%-23.91M28,063.27%13.7M2,076.50%4.63M-109.35%-292K-174.63%-100K219.74%91K-103.20%-49K
Depreciation and amortization 7.14%15K7.55%57K-71.70%15K--14K--14K--14K--53K--53K--0--0
Other non cash items ----47.23%6.35M-29.65%700K-62.61%799K---------38.29%4.31M-81.60%995K11,772.22%2.14M62.11%937K
Change In working capital 117.87%456K346.25%12.42M38.15%5.13M10.19%5.87M508.54%3.97M51.72%-2.55M297.80%2.78M256.69%3.71M1,178.74%5.33M69.47%-972K
-Change in receivables 74.15%-205K---763K---542K--210K--362K---793K--0--0--0--0
-Change in prepaid assets 70.41%-414K353.09%5.69M-39.11%1.74M73.57%2.19M243.96%3.16M66.43%-1.4M22.36%-2.25M530.12%2.86M224.02%1.26M-402.29%-2.2M
-Change in payables and accrued expense 414.12%1.09M20.75%7.55M335.17%3.95M-14.23%3.49M-62.14%463K-719.64%-347K320.65%6.26M153.20%907K679.50%4.07M144.52%1.22M
-Change in other current liabilities -15.38%-15K95.27%-58K68.63%-16K---15K---14K98.89%-13K---1.23M---51K--0--0
Cash from discontinued investing activities
Operating cash flow 55.14%-4.64M61.18%-23.91M85.40%-1.91M48.09%-5.75M71.05%-5.9M39.29%-10.35M-25.74%-61.6M28.62%-13.09M-5.37%-11.07M-129.31%-20.4M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -75.55%2.17M812.27%11.38M223.04%2.32M645.51%2.49M-1,734.92%-2.31M10,591.57%8.87M-101.43%-1.6M-109.33%-1.89M133.57%334K-100.22%-126K
Net issuance payments of debt -2.18%-1.31M-304.71%-7.64M-14.09%-2.15M---1.89M---2.31M---1.29M86.07%-1.89M---1.89M--0--0
Net common stock issuance -65.54%3.48M4,039.82%18.92M--4.48M850.33%4.34M--0--10.1M-99.61%457K--0--457K--0
Proceeds from stock option exercised by employees -93.44%4K-9.35%97K--050.00%36K--0-26.51%61K-98.57%107K--0-67.57%24K--0
Net other financing activities ---------------------------273K--0---147K----
Cash from discontinued financing activities
Financing cash flow -75.55%2.17M812.27%11.38M223.04%2.32M645.51%2.49M-1,734.92%-2.31M10,591.57%8.87M-101.43%-1.6M-109.33%-1.89M133.57%334K-100.22%-126K
Net cash flow
Beginning cash position -80.71%3M-80.27%15.53M-91.53%2.58M-85.84%5.84M-77.24%14.06M-80.27%15.53M402.71%78.73M-60.29%30.51M-52.69%41.25M59.67%61.77M
Current changes in cash -67.71%-2.47M80.16%-12.54M102.75%412K69.66%-3.26M59.96%-8.22M91.31%-1.47M-200.20%-63.2M-887.90%-14.98M-3.60%-10.74M-142.30%-20.52M
End cash Position -96.27%524K-80.71%3M-80.71%3M-91.53%2.58M-85.84%5.84M-77.24%14.06M-80.27%15.53M-80.27%15.53M-60.29%30.51M-52.69%41.25M
Free cash flow 55.14%-4.64M61.18%-23.91M85.40%-1.91M48.09%-5.75M71.05%-5.9M39.29%-10.35M-25.74%-61.6M28.62%-13.09M-5.37%-11.07M-129.31%-20.4M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg